Platform
Features
Stemina Biomarker Discovery
Contact
Don Hardison brings a broad private and public company background in both emerging and Fortune 500 companies. Mr. Hardison is currently President, CEO and Director of Biotheranostics, Inc.
13 members
Pharmacy Specialists
Salarius Pharmaceuticals
Novo Nordisk
Amplity Health
Avicenna Buying Group